FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Markus Peck-Radosavljevic

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Thomas Reiberger; Michael Trauner; Harald Vogelsang; Arnulf Ferlitsch; Hubert Hayden; Birgit B Heinisch; Frank Lammert; Mattias Mandorfer; Berit A Payer; Markus Peck-Radosavljevic
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
Thomas Reiberger; Philipp Schwabl; Michael Trauner; Bernhard Angermayr; Valentin Fuhrmann; Hubert Hayden; Thomas Horvatits; Thomas Hummel; Bernhard Jäger; Markus Mitterhauser; Berit Anna Payer; Markus Peck-Radosavljevic
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Martin Blachier; Henri Leleu; Markus Peck-Radosavljevic; Dominique-Charles Valla; Françoise Roudot-Thoraval
The burden of liver disease in Europe: a review of available epidemiological data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Markus Peck-Radosavljevic (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas Reiberger; Michael Trauner; Harald Vogelsang; Arnulf Ferlitsch; Hubert Hayden; Birgit B Heinisch; Frank Lammert; Mattias Mandorfer; Berit A Payer; Markus Peck-Radosavljevic
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
Journal of hepatology 2013;58(5):911-21.
2013: Thomas Reiberger; Philipp Schwabl; Michael Trauner; Bernhard Angermayr; Valentin Fuhrmann; Hubert Hayden; Thomas Horvatits; Thomas Hummel; Bernhard Jäger; Markus Mitterhauser; Berit Anna Payer; Markus Peck-Radosavljevic
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Liver international : official journal of the International Association for the Study of the Liver 2013;33(4):561-8.
2013: Martin Blachier; Henri Leleu; Markus Peck-Radosavljevic; Dominique-Charles Valla; Françoise Roudot-Thoraval
The burden of liver disease in Europe: a review of available epidemiological data.
Journal of hepatology 2013;58(3):593-608.
2013: M Mandorfer; B A Payer; Markus Peck-Radosavljevic; T Reiberger
The influence of portal pressure on the discordance between absolute CD4+ cell count and CD4+ cell percentage in HIV/hepatitis C virus-coinfected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(6):904-5.
2013: Mattias Mandorfer; Barbara Obermayer-Pietsch; Berit A Payer; Markus Peck-Radosavljevic; Thomas Reiberger; Armin Rieger; Michael Trauner; Maximilian C Aichelburg; Florian Breitenecker; Arnulf Ferlitsch
Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
AIDS (London, England) 2013;27(2):227-32.
2012: Ioan Sporea; Hirokazu Takahashi; Hironori Tanaka; Radu Ion Badea; Alberto Borghi; Simona Bota; Mirko D'Onofrio; Hirotoshi Ebinuma; Arnulf Ferlitsch; Carmen Fierbinteanu-Braticevici; Mireen Friedrich-Rust; Anna Gallotti; Hiroko Iijima; Monica Lupsor; Naofumi Ono; Markus Peck-Radosavljevic; Ana Petrisor; Fabio Piscaglia; Alina Popescu; Hidetsugu Saito; Christoph Sarrazin; Roxana Sirli; Mirela Danila
Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study.
European journal of radiology 2012;81(12):4112-8.
2012: L Kosi; B A Payer; T Reiberger; A Rieger; R Strassl; K Grabmeier-Pfistershammer; Markus Peck-Radosavljevic
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
Journal of viral hepatitis 2012;19(11):801-10.
2012: Monika Ferlitsch; Matthias Hoke; Berit Anna Payer; Markus Peck-Radosavljevic; Thomas Reiberger; Petra Salzl; Bernadette Schwengerer; Michael Trauner; Gregor Ulbrich; Arnulf Ferlitsch
von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Hepatology (Baltimore, Md.) 2012;56(4):1439-47.
2012: Wolfgang Sieghart; Bernhard Dauser; Hans-Peter Dienes; Jean-Francois Dufour; Hubert Hayden; Anne-Christine Piguet; Matthias Pinter; Gerald Prager; Natascha Rohr-Udilova; Markus Peck-Radosavljevic
Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
Journal of hepatology 2012;57(3):592-9.
2012: Markus Peck-Radosavljevic; Rudolf E Stauber
BCLC--now also an internationally acclaimed prognostic system?
Liver international : official journal of the International Association for the Study of the Liver 2012;32(7):1037-8.
2012: Thomas Reiberger; Markus Peck-Radosavljevic
The "pegylated" story continues--perhaps because both ends (α2a and α2b) are true?
Journal of hepatology 2012;57(1):226-8; author reply 229.
2012: Thomas Reiberger; Philipp Schwabl; Judith Stift; Michael Trauner; Arnulf Ferlitsch; Berit Anna Payer; Matthias Pinter; Markus Peck-Radosavljevic
Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.
Wiener klinische Wochenschrift 2012;124(11-12):395-402.
2012: Wolfgang Sieghart; Matthias Pinter; Michael Reisegger; Ahmed Ba-Ssalamah; Johannes Lammer; Christian Müller; Markus Peck-Radosavljevic
Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study.
European radiology 2012;22(6):1214-23.
2012: Berit A Payer; Markus Peck-Radosavljevic; Thomas Reiberger; Armin Rieger; Judith H Aberle; Peter Ferenci; Heidemarie Holzmann
IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients.
European journal of clinical investigation 2012;42(6):599-606.
2012: Matthias Pinter; Rudolf Stauber; Wolfgang Vogel; Ivo Graziadei; Birgit Grünberger; Florian Hucke; Claus Kölblinger; R Königsberg; Andreas Maieron; Christian Müller; Markus Peck-Radosavljevic; Wolfgang Sieghart
Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Radiology 2012;263(2):590-9.
2012: T Reiberger; Arnulf Ferlitsch; Monika Homoncik; B A Payer; Markus Peck-Radosavljevic; M Pinter
Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
Journal of gastroenterology 2012;47(5):561-8.
2012: Natascha Rohr-Udilova; Sandra Sagmeister; Rolf Schulte-Hermann; Wolfgang Sieghart; Dagmar Stoiber; Klaus Stolze; Linda Björkhem-Bergman; Robert Eferl; Lennart C Eriksson; Bettina Grasl-Kraupp; Hubert Hayden; Bernhard Keppler; Markus Peck-Radosavljevic
Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2012;55(4):1112-21.
2012: Markus Peck-Radosavljevic; Christina Plank; Markus Reiter; Martin Schindl; Maximilian Schöniger-Hekele; Wolfgang Sieghart; Rudolf Stauber; Rudolf Steininger; Gregor Ulbrich; Martin A Funovics; Günther Gastl; Ivo Graziadei; Thomas Gruenberger; Manfred Gschwendtner; Franz Karnel; Claus Kölblinger; Johannes Lammer; Christian Müller
Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.
Wiener klinische Wochenschrift 2012;124(3-4):104-10.
2012: Markus Peck-Radosavljevic
Back to basics: staging and prognosis in HCC for medical oncologist.
Journal of hepatology 2012;56(2):488-9.
2012: Thomas Reiberger; Armin Rieger; Brigitte Schmied; Wolfgang Sieghart; Michael Trauner; Maximilian C Aichelburg; Florian Breitenecker; Arnulf Ferlitsch; Berit A Payer; Markus Peck-Radosavljevic
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Antiviral therapy 2012;17(7):1327-34.
2012: Jerzy Jaroszewicz; Michael P Manns; Stefan Mauss; Dirk Meyer-Olson; Berit Anna Payer; Markus Peck-Radosavljevic; Thomas Reiberger; Jürgen Rockstroh; Reinhold E Schmidt; Matthias Stoll; Martin Vogel; Heiner Wedemeyer; Robert Flisiak; Patrick Ingiliz; Markus Cornberg
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection.
PloS one 2012;7(8):e43143.
2011: M Pinter; Maximilian Schöniger-Hekele; W Sieghart; Rudolf E Stauber; Wolfgang Vogel; A Weissmann; R Buder; I Graziadei; Birgit Grünberger; F Hucke; R Königsberg; G Kornek; Andreas Maieron; J Matejka; Christian Müller; Markus Peck-Radosavljevic
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Alimentary pharmacology & therapeutics 2011;34(8):949-59.
2011: Florian Hucke; Markus Peck-Radosavljevic; Maximilian Schöniger-Hekele; Wolfgang Sieghart; Christian Müller
Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?
Wiener klinische Wochenschrift 2011;123(17-18):542-51.
2011: Thomas Reiberger; Karoline Rutter; Michael Trauner; Sandra Beinhardt; Peter Ferenci; Arnulf Ferlitsch; Alfred Gangl; Harald Hofer; Michael Kundi; Berit Anna Payer; Markus Peck-Radosavljevic
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(7):602-8.e1.
2011: T Reiberger; Armin Rieger; P M Heil; L Kosi; B A Payer; Markus Peck-Radosavljevic
Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients.
The Journal of infectious diseases 2011;203(12):1802-6.
2011: Mark S Sulkowski; Curtis Cooper; Bela Hunyady; Jidong Jia; Pavel Ogurtsov; Markus Peck-Radosavljevic; Mitchell L Shiffman; Cihan Yurdaydin; Olav Dalgard
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.
Nature reviews. Gastroenterology & hepatology 2011;8(4):212-23.
2011: Markus Peck-Radosavljevic; John Boletis; Fatih Besisik; Maria Lúcia Ferraz; Laurent Alric; Didier Samuel; Diethelm Messinger; Andreas Tietz; Hugo Cheinquer
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(3):242-8.
2011: Klaus Sahora; Irene Kuehrer; Axel Eisenhut; Belgin Akan; Claus Koellblinger; Peter Goetzinger; Bela Teleky; Raimund Jakesz; Markus Peck-Radosavljevic; Ahmed Ba'ssalamah; Christoph Zielinski; Michael Gnant
NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer.
Surgery 2011;149(3):311-20.
2011: Thomas Reiberger; Armin Rieger; Lutwin Weitner; Axel Baumgarten; Stefan Christensen; Siegfried Köppe; Michael Kundi; Arend Moll; Martin Obermeier; Berit A Payer; Markus Peck-Radosavljevic
Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.
Antiviral therapy 2011;16(6):815-24.
2011: Matthias Pinter; Wolfgang Sieghart; Michael Reisegger; Friedrich Wrba; Markus Peck-Radosavljevic
Sorafenib in unresectable intrahepatic cholangiocellular carcinoma: a case report.
Wiener klinische Wochenschrift 2011;123(1-2):61-4.
2011: Wolfgang Sieghart; Xiaowei Wang; Katharina Schmid; Matthias Pinter; Franz König; Martin Bodingbauer; Fritz Wrba; Susanne Rasoul-Rockenschaub; Markus Peck-Radosavljevic
Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria.
Journal of hepatology 2011;54(1):89-97.
2010: Markus Peck-Radosavljevic
Hepatocellular carcinoma: the place of new medical therapies.
Therapeutic advances in gastroenterology 2010;3(4):259-67.
2010: Thomas Reiberger; Lana Kosi; Judith Maresch; Florian Breitenecker; Berit Anna Payer; Fritz Wrba; Armin Rieger; Alfred Gangl; Markus Peck-Radosavljevic
Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy.
The Journal of infectious diseases 2010;202(1):156-60.
2010: T Reiberger; Arnulf Ferlitsch; W Sieghart; A Kreil; F Breitenecker; A Rieger; B Schmied; Alfred Gangl; Markus Peck-Radosavljevic
HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Journal of viral hepatitis 2010;17(6):400-9.
2010: Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
[4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].
Wiener klinische Wochenschrift 2010;122(9-10):280-302.
2010: Monika Schmid; Markus Peck-Radosavljevic; Franz König; Christian Mittermaier; Alfred Gangl; Peter Ferenci
A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(4):574-82.
2010: Markus Peck-Radosavljevic; Tim F Greten; Johannes Lammer; Olivier Rosmorduc; Bruno Sangro; Armando Santoro; Luigi Bolondi
Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.
European journal of gastroenterology & hepatology 2010;22(4):391-8.
2010: Guobin He; Guann-Yi Yu; Vladislav Temkin; Hisanobu Ogata; Christian Kuntzen; Toshiharu Sakurai; Wolfgang Sieghart; Markus Peck-Radosavljevic; Hyam L Leffert; Michael Karin
Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.
Cancer cell 2010;17(3):286-97.
2010: Sibylle Pramhas; Monika Homoncik; Peter Ferenci; Arnulf Ferlitsch; Thomas Scherzer; Alfred Gangl; Markus Peck-Radosavljevic
von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4.
Antiviral therapy 2010;15(6):831-9.
2010: Gudrun Zulehner; Mario Mikula; Doris Schneller; Franziska van Zijl; Heidemarie Huber; Wolfgang Sieghart; Bettina Grasl-Kraupp; Thomas Waldhör; Markus Peck-Radosavljevic; Hartmut Beug; Wolfgang Mikulits
Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.
The American journal of pathology 2010;176(1):472-81.
2010: Markus Peck-Radosavljevic
TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect health.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(1):3-4.
2009: W Sieghart; S Fellner; T Reiberger; G Ulbrich; Arnulf Ferlitsch; Volker Wacheck; Markus Peck-Radosavljevic
Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2009;41(12):902-6.
2009: Thomas Reiberger; Bernhard Angermayr; Philipp Schwabl; Natascha Rohr-Udilova; Markus Mitterhauser; Alfred Gangl; Markus Peck-Radosavljevic
Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
Journal of hepatology 2009;51(5):865-73.
2009: Monika Schmid; Christian Mittermaier; Bernhard Voller; Veronika Fialka-Moser; Alfred Gangl; Markus Peck-Radosavljevic
Postural control in patients with liver cirrhosis: a posturographic study.
European journal of gastroenterology & hepatology 2009;21(8):915-22.
2009: Pierre-Emmanuel Rautou; Bernhard Angermayr; Juan Carlos Garcia-Pagan; Rami Moucari; Markus Peck-Radosavljevic; Sebastian Raffa; Jacques Bernuau; Bertrand Condat; Michel Levardon; Carine Yver; Guillaume Ducarme; Dominique Luton; Marie-Hélène Denninger; Dominique Valla; Aurélie Plessier
Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes.
Journal of hepatology 2009;51(1):47-54.
2009: Ahmad Jalili; Tamar Kinaciyan; Talin Barisani; Markus Peck-Radosavljevic; Georg Stingl; Alexandra Geusau; Stefan Wöhrl
Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
Iranian journal of immunology : IJI 2009;6(1):55-8.
2009: Maximilian Schöniger-Hekele; Joachim Kettenbach; Markus Peck-Radosavljevic; Christian Müller
Octreotide treatment of patients with hepatocellular carcinoma--a retrospective single centre controlled study.
Journal of experimental & clinical cancer research : CR 2009;28():142.
2009: Matthias Pinter; Wolfgang Sieghart; Ivo Graziadei; Wolfgang Vogel; Andreas Maieron; Robert Königsberg; Adalbert Weissmann; Gabriela Kornek; Christina Plank; Markus Peck-Radosavljevic
Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
The oncologist 2009;14(1):70-6.
2008: Matthias Pinter; Martina Wichlas; Katharina Schmid; Christina Plank; Christian Müller; Fritz Wrba; Markus Peck-Radosavljevic
Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial.
European journal of gastroenterology & hepatology 2008;20(10):1012-9.
2008: T Reiberger; Susanne Rasoul-Rockenschaub; Armin Rieger; Peter Ferenci; Alfred Gangl; Markus Peck-Radosavljevic
Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.
European journal of clinical investigation 2008;38(6):421-9.
2008: Thomas Reiberger; Judith H Aberle; Michael Kundi; Norbert Kohrgruber; Armin Rieger; Alfred Gangl; Heidemarie Holzmann; Markus Peck-Radosavljevic
IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.
Antiviral therapy 2008;13(8):969-76.
2008: Christian Müller; Maximilian Schöniger-Hekele; Rüdiger Schernthaner; Barbara Renner; Markus Peck-Radosavljevic; Andrea Brichta; Fritz Wrba; Martin Posch; Peter Bauer; Peter Ferenci; Alfred Gangl
Percutaneous ethanol instillation therapy for hepatocellular carcinoma - a randomized controlled trial.
Wiener klinische Wochenschrift 2008;120(19-20):608-18.
2007: Markus Peck-Radosavljevic
Review article: coagulation disorders in chronic liver disease.
Alimentary pharmacology & therapeutics 2007;26 Suppl 1():21-8.
2007: Arnulf Ferlitsch; Alexander Teml; Walter Reinisch; Gregor Ulbrich; Fritz Wrba; Monika Homoncik; Alfred Gangl; Markus Peck-Radosavljevic; Harald Vogelsang
6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
The American journal of gastroenterology 2007;102(11):2495-503.
2007: Angelo Luca; Berhard Angermayr; Guido Bertolini; Franz Koenig; Giovanni Vizzini; Martin Ploner; Markus Peck-Radosavljevic; Bruno Gridelli; Jaime Bosch
An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(8):1174-80.
2007: Martin Bodingbauer; Thomas Wekerle; B Pakrah; Paul Roschger; Markus Peck-Radosavljevic; Gerd Silberhumer; Stephan Grampp; Susanne Rockenschaub; Gabriela A Berlakovich; Rudolf Steininger; Klaus Klaushofer; Rainer Oberbauer; Ferdinand Mühlbacher
Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(7):1763-9.
2007: Wolfgang Sieghart; Thorsten Fuereder; Katharina Schmid; Daniel Cejka; Johannes Werzowa; Fritz Wrba; Xiaowei Wang; Diego Gruber; Susanne Rasoul-Rockenschaub; Markus Peck-Radosavljevic; Volker Wacheck
Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation.
Transplantation 2007;83(4):425-32.
2007: Katharina Schmid; Xiaowei Wang; Andrea Haitel; Wolfang Sieghart; Markus Peck-Radosavljevic; Martin Bodingbauer; Susanne Rasoul-Rockenschaub; Fritz Wrba
KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study.
Virchows Archiv : an international journal of pathology 2007;450(2):143-9.
2007: Carl-Erik Dempfle; Dietrich C Gulba; Carl M Kirchmaier; Robert Klamroth; Wolfgang C. Korte; Reinhard Lorenz; Markus Peck-Radosavljevic; Alex Veldman; Rainer B Zotz
[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group].
Medizinische Klinik (Munich, Germany : 1983) 2007;102(1):70-81.
2007: Melanie Blum; Christian Mueller; Markus Peck-Radosavljevic; Fritz Wrba; Gabriela A Berlakovich; Ferdinand Mühlbacher; Rudolf Steiniger; Maria Speiser; Mario Pones; Michael Hüpfl; Johannes Lammer; Joachim Kettenbach
MR-guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation.
Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy 2007;16(4):230-40.
2007: Arnulf Ferlitsch; Petra Steindl-Munda; Michael Haefner; Markus Peck-Radosavljevic; Christian Madl; Regina Pötzi; Monika Homoncik; Claudia Weidekamm; Susanne Granegger; Helmut Sinzinger
Prescintigraphic morphine application for abdominal adenocarcinoma imaging, with technetium-99m methoxy isobutyl isonitrile.
Hellenic journal of nuclear medicine 2007;10(1):14-8.
2006: Simon Panzer; Esther Seel; Markus Brunner; Günther F Körmöczi; Monika Schmid; Peter Ferenci; Markus Peck-Radosavljevic
Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia.
European journal of haematology 2006;77(6):513-7.
2006: Edoardo Giannini; Atif Zaman; Anna Kreil; Annarosa Floreani; Pietro Dulbecco; Emanuela Testa; Roya Sohaey; Peter Verhey; Markus Peck-Radosavljevic; Carlo Mansi; Vincenzo Savarino; Roberto Testa
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study.
The American journal of gastroenterology 2006;101(11):2511-9.
2006: Monika Homoncik; Wolfgang Sieghart; Elisabeth Formann; Monika Schmid; Peter Ferenci; Alfred Gangl; Bernd Jilma; Markus Peck-Radosavljevic
Erythropoietin treatment is associated with more severe thrombocytopenia in patients with chronic hepatitis C undergoing antiviral therapy.
The American journal of gastroenterology 2006;101(10):2275-82.
2006: Shuren Li; Mohsen Beheshti; Markus Peck-Radosavljevic; Simon Oezer; Elke Grumbeck; Monika Schmid; Gerhard Hamilton; Stylianos Kapiotis; Robert Dudczak; Kurt Kletter
Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(8):920-7.
2006: Karin Pieber; Richard Crevenna; Martin Nuhr; Michael Quittan; Markus Peck-Radosavljevic; Veronika Fialka-Moser; Günther F Wiesinger
Aerobic capacity, muscle strength and health-related quality of life before and after orthotopic liver transplantation: preliminary data of an Austrian transplantation centre.
Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 2006;38(5):322-8.
2006: Markus Peck-Radosavljevic
Portal hypertension--old problem, new therapeutic solutions.
Wiener medizinische Wochenschrift (1946) 2006;156(13-14):397-403.
2006: Gerd Silberhumer; Hubert Hetz; Susanne Rasoul-Rockenschaub; Markus Peck-Radosavljevic; Thomas Soliman; Rudolf Steininger; Ferdinand Muehlbacher; Gabriela A Berlakovich
Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
Transplant international : official journal of the European Society for Organ Transplantation 2006;19(4):275-81.
2006: Günther F Körmöczi; Marcus D Säemann; Christoph Buchta; Markus Peck-Radosavljevic; Wolfgang R Mayr; D W M Schwartz; Daniela Dunkler; Susanne Spitzauer; Simon Panzer
Influence of clinical factors on the haemolysis marker haptoglobin.
European journal of clinical investigation 2006;36(3):202-9.
2006: Wolfgang Sieghart; Monika Homoncik; Bernd Jilma; Elisabeth Formann; Peter Ferenci; Alfred Gangl; Markus Peck-Radosavljevic
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C.
Thrombosis and haemostasis 2006;95(2):260-6.
2006: Wolfgang Sieghart; Doris Losert; Sabine Strommer; Daniel Cejka; Katharina Schmid; Susanne Rasoul-Rockenschaub; Martin Bodingbauer; Richard Crevenna; Brett P Monia; Markus Peck-Radosavljevic; Volker Wacheck
Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
Journal of hepatology 2006;44(1):151-7.
2005: Arnulf Ferlitsch; Johannes Pleiner; Friedrich Mittermayer; Georg Schaller; Monika Homoncik; Markus Peck-Radosavljevic; Michael Wolzt
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascites.
Critical care medicine 2005;33(9):2028-33.
2005: Markus Peck-Radosavljevic; Michael Trauner; F Schreiber
Austrian consensus on the definition and treatment of portal hypertension and its complications.
Endoscopy 2005;37(7):667-73.
2005: Monika Schmid; Anna Kreil; Wolfgang Jessner; Monika Homoncik; Christian Datz; Alfred Gangl; Peter Ferenci; Markus Peck-Radosavljevic
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.
Gut 2005;54(7):1014-20.
2005: Georg-Christian Funk; Daniel Doberer; Christoph H Osterreicher; Markus Peck-Radosavljevic; Monika Schmid; Bruno Schneeweiss
Equilibrium of acidifying and alkalinizing metabolic acid-base disorders in cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(3):505-12.
2005: Thomas Rand; Christian Loewe; Maria Schoder; Maria Theresa Schmook; Markus Peck-Radosavljevic; Joachim Kettenbach; Florian Wolf; Barbara Schneider; Johannes Lammer
Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
Cardiovascular and interventional radiology 2005;28(3):313-8.
2005: Claudia Weidekamm; Manfred Cejna; Ludwig Kramer; Markus Peck-Radosavljevic; Till R Bader
Effects of TIPS on liver perfusion measured by dynamic CT.
AJR. American journal of roentgenology 2005;184(2):505-10.
2005: Monika Homoncik; Arnulf Ferlitsch; Peter Ferenci; Elisabeth Formann; Bernd Jilma; Alfred Gangl; Simon Panzer; Markus Peck-Radosavljevic
Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C.
Alimentary pharmacology & therapeutics 2005;21(1):49-55.
2004: Gabriela A Berlakovich; Thomas Soliman; Edith Freundorfer; Thomas Windhager; Martin Bodingbauer; Peter Wamser; Hubert Hetz; Markus Peck-Radosavljevic; Ferdinand Muehlbacher
Pretransplant screening of sobriety with carbohydrate-deficient transferrin in patients suffering from alcoholic cirrhosis.
Transplant international : official journal of the European Society for Organ Transplantation 2004;17(10):617-21.
2004: Bernhard Angermayr; Manfred Cejna; Franz Karnel; Michael Gschwantler; Franz König; Johann Pidlich; Helmuth Mendel; Harald Brunner; Ludwig Pichler; Peter Ferenci; Johannes Lammer; Alfred Gangl; Markus Peck-Radosavljevic
Transjugular intrahepatic portosystemic shunt in Vienna--a decade later.
Wiener klinische Wochenschrift 2004;116(17-18):608-13.
2004: Shuren Li; Markus Peck-Radosavljevic; Oskar Kienast; Josef Preitfellner; Ernst Havlik; Wolfgang Schima; Tatjana Traub-Weidinger; Senta Graf; Mohsen Beheshti; Monika Schmid; Peter Angelberger; Robert Dudczak
Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2004;48(3):198-206.
2004: Monika Homoncik; Petra Jilma-Stohlawetz; Monika Schmid; Arnulf Ferlitsch; Markus Peck-Radosavljevic
Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double-blind, placebo-controlled study.
Alimentary pharmacology & therapeutics 2004;20(4):437-43.
2004: Arnulf Ferlitsch; Anna Kreil; Edith Bauer; Herwig Schmidinger; Martin Schillinger; Alfred Gangl; Markus Peck-Radosavljevic
Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma.
European journal of clinical investigation 2004;34(3):218-23.
2003: Bernhard Angermayr; Manfred Cejna; Franz Koenig; Franz Karnel; Franz Hackl; Alfred Gangl; Markus Peck-Radosavljevic
Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.
Hepatology (Baltimore, Md.) 2003;38(4):1043-50.
2003: Shuren Li; Markus Peck-Radosavljevic; Oskar Kienast; Josef Preitfellner; Gerhard Hamilton; Amir Kurtaran; Christian Pirich; Peter Angelberger; Robert Dudczak
Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1274-7.
2003: Bernhard Angermayr; Manfred Cejna; Franz Karnel; Michael Gschwantler; Franz Koenig; Johann Pidlich; H Mendel; L Pichler; Martina Wichlas; Anna Kreil; Monika Schmid; Arnulf Ferlitsch; E Lipinski; Harald Brunner; Johannes Lammer; Peter Ferenci; Alfred Gangl; Markus Peck-Radosavljevic
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.
Gut 2003;52(6):879-85.
2003: Edmund Cauza; Markus Peck-Radosavljevic; Herbert Ulrich-Pur; Christian Datz; Michael Gschwantler; Maximilian Schöniger-Hekele; Franz Hackl; Claudia Polli; Susanne Rasoul-Rockenschaub; Christian Müller; Fritz Wrba; Alfred Gangl; Peter Ferenci
Mutations of the HFE gene in patients with hepatocellular carcinoma.
The American journal of gastroenterology 2003;98(2):442-7.
2002: Harald Hofer; Hans C Bankl; Fritz Wrba; Petra Steindl-Munda; Markus Peck-Radosavljevic; Christoph H Osterreicher; Christian Mueller; Alfred Gangl; Peter Ferenci
Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.
The American journal of gastroenterology 2002;97(11):2880-5.
2002: Manfred Cejna; Markus Peck-Radosavljevic; Siegfried Thurnher; Maria Schoder; Thomas Rand; Bernhard Angermayr; Johannes Lammer
ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
Cardiovascular and interventional radiology 2002;25(5):365-72.
2002: Markus Peck-Radosavljevic; Martina Wichlas; Monika Homoncik-Kraml; Anna Kreil; Harald Hofer; Wolfgang Jessner; Alfred Gangl; Peter Ferenci
Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha.
Gastroenterology 2002;123(1):141-51.
2002: Bernhard Angermayr; Manfred Cejna; Maria Schoder; Fritz Wrba; Peter Valent; Alfred Gangl; Markus Peck-Radosavljevic
Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis.
Blood 2002;99(11):4246-7.
2002: Manfred Cejna; Markus Peck-Radosavljevic; Maria Schoder; Siegfried Thurnher; Ahmed Ba-Ssalamah; Bernhard Angermayr; Klaus Kaserer; Boris Pokrajac; Johannes Lammer
Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome.
Journal of vascular and interventional radiology : JVIR 2002;13(2 Pt 1):193-9.
2001: Günther F Wiesinger; Michael Quittan; K Zimmermann; Martin Nuhr; Martina Wichlas; Martin Bodingbauer; Reza Asari; Gabriela A Berlakovich; Richard Crevenna; Veronika Fialka-Moser; Markus Peck-Radosavljevic
Physical performance and health-related quality of life in men on a liver transplantation waiting list.
Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 2001;33(6):260-5.
2001: Manfred Cejna; Markus Peck-Radosavljevic; Siegfried Thurnher; K Hittmair; Maria Schoder; Johannes Lammer
Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis.
Radiology 2001;221(2):437-46.
2001: Markus Peck-Radosavljevic
Hypersplenism.
European journal of gastroenterology & hepatology 2001;13(4):317-23.
2001: Shuren Li; Markus Peck-Radosavljevic; Elisabeth Koller; Franz Koller; Klaus Kaserer; Anna Kreil; S Kapiotis; Ahmad Hamwi; H A Weich; Peter Valent; Peter Angelberger; Robert Dudczak; Irene Virgolini
Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy.
International journal of cancer. Journal international du cancer 2001;91(6):789-96.
2000: Markus Peck-Radosavljevic; Johann Pidlich
[Transjugular intrahepatic portosystemic shunt (TIPS)].
Wiener klinische Wochenschrift 2000;112(22):947-54.
2000: Anna Kreil; Christoph Wenisch; G Brittenham; Sornchai Looareesuwan; Markus Peck-Radosavljevic
Thrombopoietin in Plasmodium falciparum malaria.
British journal of haematology 2000;109(3):534-6.
2000: Markus Peck-Radosavljevic; Martina Wichlas; Johannes Zacherl; Gabriele Stiegler; PJ Stohlawetz; Michael Fuchsjäger; Anna Kreil; SM Metz-Schimmerl; Simon Panzer; Rudolf Steininger; Ferdinand Mühlbacher; Peter Ferenci; Johann Pidlich; Alfred Gangl
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production.
Blood 2000;95(3):795-801.
1999: Markus Peck-Radosavljevic; Andreas Püspök; Regina Pötzi; Georg Oberhuber
Histological findings after routine biopsy at the gastro-oesophageal junction.
European journal of gastroenterology & hepatology 1999;11(11):1265-70.
1999: Peter Smith-Jones; C Bischof; Maria Leimer; D Gludovacz; Peter Angelberger; T Pangerl; Markus Peck-Radosavljevic; Gerhard Hamilton; Klaus Kaserer; A Kofler; H Schlangbauer-Wadl; Tatjana Traub; Irene Virgolini
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
Endocrinology 1999;140(11):5136-48.
1999: Markus Peck-Radosavljevic; R Prokesch; K Schmid; M Frossard; Martina Wichlas; Alexandra Gendo; Alfred Gangl; Christian Madl
Fulminant lethal tuberculous pneumonia (Sepsis tuberculosis gravissima) with ARDS in a non-immunocompromised western European middle-aged man.
Wiener klinische Wochenschrift 1999;111(4):157-60.
1999: Markus Peck-Radosavljevic; Johannes Zacherl; Martina Wichlas; Paul Sims; Y Gloria Meng; Simon Panzer; E Lipinski; Rudolf Steininger; Ferdinand Mühlbacher; Johann Pidlich; Alfred Gangl
Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation.
European journal of gastroenterology & hepatology 1999;11(2):151-6.
1998: Markus Peck-Radosavljevic; Martina Wichlas; Johann Pidlich; Paul Sims; G Meng; Johannes Zacherl; S Garg; Christian Datz; Alfred Gangl; Peter Ferenci
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C.
Hepatology (Baltimore, Md.) 1998;28(5):1424-9.
1998: Gabriele Stiegler; PJ Stohlawetz; Markus Peck-Radosavljevic; Bernd Jilma; Johann Pidlich; Martina Wichlas; Paul Höcker; Simon Panzer
Direct evidence for an increase in thrombopoiesis after liver transplantation.
European journal of clinical investigation 1998;28(9):755-9.
1998: Irene Virgolini; Amir Kurtaran; Maria Leimer; Klaus Kaserer; Markus Peck-Radosavljevic; Peter Angelberger; P Hübsch; M Dvorak; Peter Valent; Bruno Niederle
Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(9):1575-9.
1998: Irene Virgolini; Maria Leimer; Hirsch Handmaker; Secondo Lastoria; C Bischof; Pietro Muto; T Pangerl; D Gludovacz; Markus Peck-Radosavljevic; J Lister-James; Gerhard Hamilton; Klaus Kaserer; Peter Valent; R Dean
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829.
Cancer research 1998;58(9):1850-9.
1998: Markus Peck-Radosavljevic; Johann Pidlich; M Bergmann; Peter Ferenci; C Seelos; Martina Wichlas; E Lipinski; M Gnant; Alfred Gangl; Ferdinand Mühlbacher
Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group.
Journal of hepatology 1998;28(3):497-503.
1998: Johann Pidlich; Markus Peck-Radosavljevic; A Kranz; R Wildling; FW Winkelbauer; Johannes Lammer; C Mayer; Christian Müller; Günter Stix; Alfred Gangl; Herwig Schmidinger
Transjugular intrahepatic portosystemic shunt and cardiac arrhythmias.
Journal of clinical gastroenterology 1998;26(1):39-43.
1997: Irene Virgolini; T Pangerl; C Bischof; Peter Smith-Jones; Markus Peck-Radosavljevic
Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer?
European journal of clinical investigation 1997;27(8):645-7.
1997: Markus Peck-Radosavljevic; Johannes Zacherl; Y Gloria Meng; Johann Pidlich; E Lipinski; Friedrich Längle; Rudolf Steininger; Ferdinand Mühlbacher; Alfred Gangl
Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?
Journal of hepatology 1997;27(1):127-31.
1997: Christian Müller; F Pfeffel; Markus Peck-Radosavljevic; Dagmar Petermann; C Oesterreicher; Johann Pidlich
Prevalence of hepatitis G virus in patients with hepatocellular carcinoma.
Journal of viral hepatitis 1997;4(6):411-4.
1997: Johann Pidlich; G M Cichini; W Reinisch; Markus Peck-Radosavljevic; F Renner
Angiotensin-converting enzyme inhibition in cirrhotic patients--pharmacokinetics of ramipril.
Acta medica Austriaca 1997;24(1):15-8.
1996: Irene Virgolini; Peter Angelberger; S Li; Q Yang; Amir Kurtaran; Markus Raderer; Nikolaus Neuhold; Klaus Kaserer; Maria Leimer; Markus Peck-Radosavljevic; Werner Scheithauer; Bruno Niederle; H G Eichler; Peter Valent
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
European journal of nuclear medicine 1996;23(10):1388-99.